Quality assurance for biogenic amines with authentic patient specimens

Pillai, Dilo N.; Earl, John

doi:10.3109/00313029109061432

Cited by 7 publications

(6 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…GC/MS is the most commonly used mass spectrometric method for catecholamine and catecholamine metabolite analysis. − Pheochromocytomas have been diagnosed with these methods . Furthermore, applications of GC/MS has also been used for the diagnosis of neuroblastomas. , Most methods incorporate isotope dilution techniques in their mass spectrometric analysis, with special attention to quality assurance . Analyte-specific methods have been developed for specific disorders.…”

Section: G Biogenic Aminesmentioning

confidence: 99%

“…Examples of quality assurance systems developed for mass spectrometric assays have been described for applications that involve newborn screening. ,,, It is noteworthy that, to ensure implementation of a quality assurance program in a laboratory that performs clinical analysis, the laboratory must meet Federal laboratory accreditation requirements as defined by CLIA (Clinical and Laboratory Improvement Act) of 1988. Research assays must be clearly delineated from routine clinical assays and cannot be used to report patient results.…”

Section: B Quality Assurancementioning

confidence: 99%

“…Research assays must be clearly delineated from routine clinical assays and cannot be used to report patient results. Several investigators have addressed quality assurance and the use of mass spectrometric based assays by developing standards, reference materials, isotope dilution techniques, laboratory comparisons, and external assessments. ,,,,− …”

Section: B Quality Assurancementioning

confidence: 99%

“…271,272 Most methods incorporate isotope dilution techniques in their mass spectrometric analysis, with special attention to quality assurance. 273 Analyte-specific methods have been developed for specific disorders. For example, GC/MS has been used to analyze dopamine 274,275 in research and clinical investigations of Parkinson's disease.…”

Section: G Biogenic Aminesmentioning

confidence: 99%

See 3 more Smart Citations

Mass Spectrometry in the Clinical Laboratory

2001

View full text Add to dashboard Cite

Section: G Biogenic Aminesmentioning

confidence: 99%

Section: B Quality Assurancementioning

confidence: 99%

Section: B Quality Assurancementioning

confidence: 99%

Section: G Biogenic Aminesmentioning

confidence: 99%

See 2 more Smart Citations

Mass Spectrometry in the Clinical Laboratory

2001

View full text Add to dashboard Cite

“…Similar surveys in the United Kingdom show that a number of laboratories continue to use inappropriate screening tests. 7 • S…”

mentioning

confidence: 99%

Laboratory Diagnosis of Phaeochromocytoma: Which Analytes Should We Measure?

et al. 1993

View full text Add to dashboard Cite

SUMMARY. There is a diversity of advice in the literature as to which biochemical assays are best suited to the investigation of patients with a suspected phaeochromocytoma. The challenge for the clinical laboratory is to select those assays which detect all phaeochromocytomas, whilst having the lowest incidence of false positive diagnoses. We compared the sensitivity and specificity of a wide range of assays currently used for the biochemical diagnosis of phaeochromocytoma using either specific gas chromatographic-mass spectrometric (GC/MS) or high performance liquid chromatography-electrochemical detection (HPLC/ED) techniques.Noradrenaline (NA), adrenaline (ADR), dopamine (DA), 3,4-dihydroxyphenylglycol (DHPG), hydroxymethoxymandelic acid (HMMA), normetanephrine (NMET) and metanephrine (MET) were measured in 24 h urine specimens from 20 patients with histologically proven phaeochromocytoma and a large group of patients referred for investigation but subsequently found not to have a phaeochromocytoma. Because phaeochromocytomas are a heterogeneous group of hormone secreting tumours, no single analyte could achieve 100D,10 sensitivity; 100% sensitivity was achieved only when the combination of both NA and ADR or NMET and MET was used. DA, DHPG and HMMA all had poor sensitivities. HMMA had a sensitivity of 70% when using the upper 95% confidence level (48 p.mol/24 h) of the non-tumour patients as the cut-off. By lowering the cut-off to 35 p.mo1124 h the sensitivity could be increased to 100% but at the expense of the specificity which was decreased from 98 to 92%. On the basis of this study we recommend the specific measurement of either NA and ADR or NMET and MET as the most suitable analytes for the detection of phaeochromocytoma, and further that, due to its poor specificity, HMMA be abandoned as a suitable analyte. Additional key phrases: catecholamines; metanephrines; gas chromatography-mass spectrometry; high performance liquid chromatographyDespite recent advances in imaging technology, quantitative determinations of catecholamines and their metabolites remain the main diagnostic tool for the detection of phaeochromocytorna."? As a missed diagnosis may lead to a fatal outcome, it is vital that the screening test performed by the laboratory is the best available. We have previously reported that phaeochromocytomas are a heterogeneous group of tumours with a variety of excretion patterns and that laboratories screening for phaeochromocytoma must measure appropriate analytes able to encompass the full spectrum of Correspondence: Mr P E Graham. hormone production.4.~To date, various studies have differed as to which tests are superior and should be recommended for screening.t-"The need to use appropriate technology is highlighted by poor performance in Australian quality assurance surveys by a significant number of laboratories which are still using outmoded spectrophotometric assays based on the Pisano technique for the measurement of catecholamine metabolites." Similar surveys in the United Kingdom show tha...

show abstract